Key facts
- This page summarizes Peter Gray's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Aug 2022, 17:03.
Peter Gray - 18 Aug 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)
- Reporting relationship
- Director
- Issuer ticker
- JAZZ
- Reported as of
- 18 Aug 2022
- Net transaction value
- -$821,760
- SEC form
- 4
- Accepted by SEC
- 22 Aug 2022, 17:03:47 UTC
- Prior SEC filing
- 09 Aug 2022
- Next SEC filing
- 15 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/Adam Guttmann, as attorney in fact For: Peter Gray
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Gray filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 22 Aug 2022.
Change
- Previous filing in this sequence was filed on 09 Aug 2022.
- Current net transaction value: -$821,760.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $442,240
- Shares
- +8,000
- Change %
- +56%
- Price
- $55.28
- Shares after
- 22,234
- Date
- 18 Aug 2022
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $1,264,000
- Shares
- -8,000
- Change %
- -36%
- Price
- $158.00
- Shares after
- 14,234
- Date
- 18 Aug 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JAZZ
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -8,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Aug 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 8,000
- Exercise price
- $55.28
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vested over three years from the Vesting Commencement Date, with 1/3 that vested on the first anniversary of the Vesting Commencement Date and the remainder vested in 24 equal monthly installments thereafter.